Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taro Pharm Inds (NY: TARO )

42.45 -0.06 (-0.14%)
Official Closing Price Updated: 4:10 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Form 6-K
Source: SEC/Edgar
September 22, 2010
Form SC TO-T/A
Source: SEC/Edgar
September 21, 2010
Form SC TO-T/A
Source: SEC/Edgar
September 14, 2010
Form SC 13D/A
Source: SEC/Edgar
September 09, 2010
Form SC TO-T/A
Source: SEC/Edgar
September 09, 2010
Form SC 14D9/A
Source: SEC/Edgar
September 07, 2010
Form SC TO-T/A
Source: SEC/Edgar
September 06, 2010
Form 6-K
Source: SEC/Edgar
August 24, 2010
Form 6-K
Source: SEC/Edgar
August 03, 2010
Form NTN 20F
Source: SEC/Edgar
July 29, 2010
Form SC TO-T/A
Source: SEC/Edgar
July 28, 2010
Form SC TO-T/A
Source: SEC/Edgar
July 14, 2010
Form SC 14D9/A
Source: SEC/Edgar
June 01, 2010
Form 6-K
Source: SEC/Edgar
May 24, 2010
Form 6-K
Source: SEC/Edgar
May 06, 2010
Form 6-K
Source: SEC/Edgar
May 06, 2010
Form 6-K
Source: SEC/Edgar
April 29, 2010
Form 20-F
Source: SEC/Edgar
April 12, 2010
Form 6-K
Source: SEC/Edgar
March 24, 2010
Form SC TO-T/A
Source: SEC/Edgar
February 07, 2010
Form SC 13D/A
Source: SEC/Edgar
January 10, 2010
Form SC TO-T/A
Source: SEC/Edgar
January 10, 2010
Form 6-K
Source: SEC/Edgar
December 30, 2009
Form SC TO-T/A
Source: SEC/Edgar
December 30, 2009
Form SC 13D/A
Source: SEC/Edgar
December 30, 2009
Form SC 13D/A
Source: SEC/Edgar
December 23, 2009
Form SC TO-T/A
Source: SEC/Edgar
December 23, 2009
Form SC 14D9/A
Source: SEC/Edgar
December 22, 2009
Form SC TO-T/A
Source: SEC/Edgar
December 21, 2009
Form SC 13D/A
Source: SEC/Edgar
December 21, 2009
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.